All Articles

While headlines focus on AI, Syntec Optics is quietly building the foundational hardware that gives soldiers superhuman vision. A look at the unseen progress.

The e-commerce giant reports a tripling of brand protection efforts. But do the impressive numbers translate to a safer marketplace for brands and consumers?

A massive concrete segment was hoisted over Bhopal, a milestone in the city's metro project. It's more than engineering; it's the future of urban life arriving.

A startup led by a former Marine Intel Officer just raised $4M. The deal signals a major shift in how venture capital views the future of work in construction.

Voyager Therapeutics' new gene therapy just cleared a key FDA hurdle. With promising preclinical data, it's a major momentum signal in the fight against Alzheimer's.

Beyond the shower puff: Cleanlogic's new line embeds skincare into bath tools. But its exclusive Ulta launch is a masterclass in strategic growth.

We-Vibe and Adam & Eve are taking sexual wellness on the road. It's more than a marketing stunt; it's a look at the future of experiential retail.

Riverside Resources is spinning out Ravena Resources, replicating a strategy that launched two other public companies. Is this a blueprint for success?

A Canadian firm hits record gas production in Uzbekistan, hailing a repeatable success model. But can it balance fossil fuel growth with its 'energy transition' identity?

By hiring top drug and deal makers, Bexorg signals its AI-powered human brain platform is ready to move from a bold experiment to a commercial powerhouse.

o9 Solutions' promotion of an insider as COO isn't a simple C-suite shuffle. It's a clear signal of its ambition to move beyond AI tech to redefine how companies operate.

An agency's award win signals a seismic shift in online visibility. Beyond traditional SEO, a new strategy called GEO is delivering triple-digit growth by optimizing for AI.

As rivals chase the novelty of an 'AI board member,' Indianapolis-based OnBoard is betting on a different future: one where AI serves human leaders.

A breakthrough study shows a wearable ear device can stimulate nerves to enhance the body’s natural clotting, offering a drug-free future for saving lives.

After an initial rejection, Sydnexis's pediatric myopia drug gets a crucial FDA hearing, raising hopes for the first approved U.S. pharmaceutical treatment.

Dextra Partners' new VP isn't just a new hire; he's a signal. We deconstruct why firms are now hunting for 'full toolkit' talent to build resilient firms.

Alarum Technologies faces an existential threat after FBI seizures. With a third of its staff cut and no answers, the company's future hangs in the balance.

Kahuna Labs' new AI module analyzes support interactions to find hidden growth opportunities, transforming a reactive department into a strategic source of revenue.